CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-02 | Guyer William Chief Development Officer | Sale 10b5-1 | −19,360 | $80.05 | $1.5M | 1,875 |
| 2025-12-02 | Guyer William Chief Development Officer | Sale 10b5-1 | −640 | $80.88 | $52K | 1,235 |
| 2025-12-02 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 270,000 | ||
| 2025-12-02 | Maduck Sean See Remarks | Shares withheld for taxes 10b5-1 | −135 | $79.78 | $11K | 8,179 |
| 2025-12-02 | Lyon Joseph Douglas See Remarks | Shares withheld for taxes 10b5-1 | −110 | $79.78 | $9K | 10,523 |
| 2025-12-02 | Mokari Atabak Chief Financial Officer | Shares withheld for taxes | −118 | $79.78 | $9K | 14,559 |
| 2025-12-02 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −148 | $79.78 | $12K | 13,910 |
| 2025-12-01 | Guyer William Chief Development Officer | Grant or award 10b5-1 | +224 | $79.78 | $18K | 224 |
| 2025-12-01 | Guyer William Chief Development Officer | Grant or award 10b5-1 | +224 | 448 | ||
| 2025-12-01 | Maduck Sean See Remarks | Option exercise 10b5-1 | +20,000 | $8.27 | $165K | 27,904 |
| 2025-12-01 | Maduck Sean See Remarks | Sale 10b5-1 | −20,000 | $79.52 | $1.6M | 7,904 |
| 2025-12-01 | Maduck Sean See Remarks | Grant or award 10b5-1 | +205 | $79.78 | $16K | 8,109 |
| 2025-12-01 | Maduck Sean See Remarks | Grant or award 10b5-1 | +205 | 8,314 | ||
| 2025-12-01 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 241,986 | ||
| 2025-12-01 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +5,000 | $13.56 | $68K | 15,277 |
| 2025-12-01 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −5,000 | $79.53 | $398K | 10,277 |
| 2025-12-01 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +178 | $79.78 | $14K | 10,455 |
| 2025-12-01 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +178 | 10,633 | ||
| 2025-12-01 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 11,571 | ||
| 2025-12-01 | Mokari Atabak Chief Financial Officer | Grant or award | +178 | $79.78 | $14K | 14,499 |
Page 16 of 61 · 1,220 trades